Title : Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.

Pub. Date : 2008 Apr

PMID : 18187583






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium assays demonstrated that EGFR and k-Ras mutations were related to erlotinib sensitivity, whereas TS and DHFR expression were related to pemetrexed sensitivity. thiazolyl blue epidermal growth factor receptor Homo sapiens